Abstract. In this study, we investigated the effect of vesicular zinc on ischemic neuronal injury. In cultured neurons, addition of a low concentration (under 100 µM) of zinc inhibited both glutamate-induced calcium influx and neuronal death. In contrast, a higher concentration (over 150 µM) of zinc decreased neuronal viability, although calcium influx was inhibited. These results indicate that zinc exhibits biphasic effects depending on its concentration. Furthermore, in cultured neurons, co-addition of glutamate and CaEDTA, which binds extra-cellular zinc, increased glutamate-induced calcium influx and aggravated the neurotoxicity of glutamate. In a rat transient middle cerebral artery occlusion (MCAO) model, the infarction volume, which is related to the neurotoxicity of glutamate, increased rapidly on the intracerebral ventricular injection of CaEDTA 30 min prior to occlusion. These results suggest that zinc released from synaptic vesicles may provide a protective effect against ischemic neuronal injury.
Introduction
The brain contains an abundant amount of zinc, particularly in the hippocampus, cerebral cortex, and limbic system. About 10% of all zinc in the brain exists in the presynaptic vesicles of glutamatergic neurons and it is released into synaptic clefts upon the excitation of nerves (1 -4) . Furthermore, some studies reported that zinc inhibits N-methyl-D-asparate (NMDA) receptors by interacting with the zinc binding site on the receptors (5 -7) and the release of glutamate (8, 9) . On the other hand, the influx of calcium through NMDA receptors induced by glutamate, which is excessively released from glutamatergic nerve terminals into synaptic clefts during brain ischemia, is thought to relate to neuronal death after ischemia (10, 11) . Thus, these studies suggest that zinc, which is released from synaptic vesicles during brain ischemia along with glutamate, may exert a protective effect against glutamate-induced neuronal injury by blocking the influx of calcium via NMDA receptors, but the effect of synaptic vesicular zinc on ischemic neuronal injury is still unclear.
In this study, we investigate the effect of vesicular zinc on ischemic neuronal injury using cultured hippocampal neurons and transient middle cerebral artery occlusion (MCAO) in rats.
Materials and Methods

[
45 Ca]Calcium chloride (50 mCi (1.85 GBq)/ mg Ca) was purchased from Amersham Pharmacia Biotec UK, Ltd. (Buckinghamshire, UK). All other chemicals were of reagent grade and purchased commercially. Male Sprague-Dawley rats (280 to 320 g) were obtained from Japan SLC Co. (Hamamatsu). All animal experiments were performed in accordance with our institutional guidelines, and the experimental procedures were approved by the Kyoto University Animal Care Committee.
Cell culture
Primary hippocampal neuronal cultures were established essentially according to the methods of Banker and Cowan (12) .
Hippocampi were excised from 18-day-old SpragueDawley rat embryos, trypsinized, and triturated by pipeting through a narrow-pore pipette. Cultures were plated onto polyethylenimine-coated 48-well plastic plates at a density of 1.2 × 10 5 per well. The cultures were maintained in Eagle's minimal essential medium (MEM Eagle's salt) containing 10% heat-inactivated fetal bovine serum (1 -3 days after plating) or N-2 supplement (4 -12 days after plating), streptomycin (25 U/ ml), penicillin (25 µg/ ml), glutamine (2 mM), glucose (total 11 mM), NaHCO 3 (26 mM), and N- [2-hydroxyethyl] pyperazin-N-[2-ethansulfoic acid] (HEPES) (10 mM) at 37°C in a humidified 10% CO 2 / 90% air mixture. Only mature cells (9 -10 days in vitro) were used in this study. Immunocytochemical analysis of these primary cultures showed that they contained >90% neurons and <10% glia or other contaminating cells.
Measurement of neurotoxicity
Exposure to glutamate was carried out in Locke's solution (154 mM NaCl, 5.6 mM KCl, 1.2 mM MgCl 2 , 2.3 mM CaCl 2 , 5.6 mM glucose, 3.6 mM NaHCO 3 , and 5 mM HEPES, adjusted to pH 7.4 with NaOH). The cultures were exposed to 1 mM glutamate for 10 min and then incubated in glutamate-free buffer for 60 min. The test agents were co-administered with glutamate.
The neurotoxic effect of glutamate was quantitatively assessed by examining cultures under a Hoffman modulation microscope (Nikon ecrips 300; Nikon, Tokyo) at ×200. After drug treatment, cell cultures were stained with 1.5% Trypan blue for 4 min at 37°C and then rinsed with physiological saline. Cells stained by Trypan blue were regarded as non-viable. More than 200 cells in each well were counted to determine the viability of the cultures.
Measurement of
45
Ca
2+ uptake
45
Ca 2+ uptake was studied as described by Wroblewski et al. (13) . Briefly, 9-day old cultures were washed with Locke's solution (pH 7.4) and preincubated with 1 ml of 45 
Ca
2+ (2 µCi/ ml, 74 kBq / ml) for 10 min to allow equilibration of the radioactive tracer in the various compartments. Cultures were then exposed to 1 mM glutamate for 10 min and incubated in glutamate-free buffer for 60 min with 45 Ca 2+ (2 µCi / ml, 74 kBq / ml). The test agents were co-administered with glutamate.
45
Ca
2+ uptake was terminated by washing the cultures with an ice-cold solution containing 154 mM choline chloride, 5 mM O,O'-bis(2-aminoethyl)ethylenglycol-N,N,N',N'-tetraacetic acid (EGTA) and 10 mM TrisHCl, pH 7.4. Cells were dissolved in 0.1 N NaOH, and radioactivity was measured with a liquid scintillation counter (2300TR Liquid Scintillation Analyzer; Packard, Meriden, CT, USA).
Middle cerebral artery occlusion
An intraluminal occluder was made of 4-0 surgical nylon monofilament "Ethilon" (Ethicon Co., Inc., Somerville, NJ, USA). The tips of the occluders were rounded by flame heating but not coated with silicone, as in the method of Zea Longa et al. (14) .
Animals, fasted overnight before the experiment but allowed free access to water, were anestheized with chloral hydrate (400 mg / kg, i.p). A polyethylene catheter (PE-50) was introduced into the left femoral artery for sampling of blood for analysis of blood gases before, during, and after MCAO. Body temperature was monitored with a rectal probe and maintained at 37°C with a heat lamp and a heating pad during the operation.
The ostium of the right middle cerebral artery (MCA) in each rat was occluded intraluminally as described by Minematsu et al. (15) . Briefly, an occluder was inserted through the right common carotid artery (CCA) for approximately 17 mm from the CCA bifurcation to occlude the ostium of the right MCA. At 60 min after the occlusion, the blood flow was recirculated by removing the occluder. The animals were permitted to recover from the anesthesia at room temperature.
Measurement of infarction volume
At 3, 6, and 24 h after ischemia, the animals were decapitated and brains were quickly removed and frozen in a hexane-dry ice bath. The brains were sectioned coronally 20-µm-thick with a cryostat at 500-µm intervals. The brain sections were stained with cresyle violet and the areas of striatal and cortical damage were quantitatively assessed using an image analyzer system (EXCEL TPVIP-4100; Japan Abionics, Tokyo). To avoid overassessing infarction volumes caused by edema, infarction volumes were indirectly calculated according to the method of Swanson et al. (16) with a modification. The lowest optical density of gray matter in the unlesioned hemisphere was used as the threshold value and areas with an optical density greater than the threshold were measured as noninfarcted. The noninfarcted volume was calculated by multiplying the sum of the noninfarcted areas by the distance between sections. The noninfarcted volume of the lesioned hemisphere was calculated in the same way. The infarcted volume was determined by subtracting the noninfarcted volume of the lesioned hemisphere from that of the unlesioned hemisphere.
Drug administration
For intracerebral ventricular (i.c.v.) injection, a stainless steel guide cannula was stereotaxically (P 0.8, L 1.5, H 2.0 mm) implanted on the right side according to the atlas of Paxinos and Watson (17) . Through an injection cannula, which reached the right lateral ventricle (P 0.8, L 1.5, H 4.0 mm), 5 µl of normal saline or 100 mM CaEDTA or ZnEDTA in saline was injected at the rate of 5 µl / min for 1 min, at 30 min before the onset of ischemia.
Statistical analyses
Data are expressed as the mean ± S.D. The statistical significance of the data was determined with Dunnett's test for multiple comparisons.
Results
Effects of different concentrations of zinc on glutamateinduced calcium influx and neurotoxicity in cultured hippocampal neurons
We examined the effect of different concentrations of zinc on the glutamate-induced calcium influx and neurotoxicity in cultured hippocampal neurons. A low concentration (under 50 µM) of zinc inhibited both glutamate-induced calcium influx and neuronal death in a concentration-dependent manner ( Figs. 1 and 2) . Furthermore, the addition of 100 µM of zinc also exhibited a significant protective effect against glutamate-induced neurotoxicity, although the viability at this point was slightly lower than that at 50 µM of zinc. In contrast, a higher concentration (over 150 µM) of zinc decreased neuronal viability, although the calcium influx remained inhibited (Figs. 1 and 2 ).
Effects of chelators on glutamate-induced calcium influx and neurotoxicity in cultured hippocampal neurons
We examined the effect of chelation of endogenous zinc on the glutamate-induced calcium influx and neurotoxicity in cultured hippocampal neurons. TPEN, a chelating agent with membrane permeability, enhanced the calcium influx (Fig. 3) and neurotoxicity (Fig. 4) . CaEDTA, a membrane impermeable compound that is able to bind zinc, exhibited the same effects as TPEN. In contrast, ZnEDTA which does not reduce zinc, had no effect on the glutamate-induced calcium influx and neurotoxicity. None of the chelators used in this study had an effect on neuronal viability (Fig. 4) . Effect of CaEDTA on infarction volume after transient MCAO in rat Figure 5 demonstrates the effect of i.c.v. injection of CaEDTA on infarction volume at 3, 6, and 24 h after MCAO in rats. The CaEDTA-treated group exhibited a significantly larger infarction volume than the salinetreated group at 3 and 6 h after ischemia, although it eventually showed the same infarction volume as the saline-treated group at 24 h after ischemia. In contrast, ZnEDTA exhibited no significant effect compared with saline at any time point. There were no significant differences in rectal temperature or other physiological parameters throughout the ischemic period in these experiments (Table 1) .
Discussion
In this study, we investigated the effect of zinc on ischemic neuronal injury in vitro and in vivo.
In cultured hippocampal neurons, we examined the effect of different concentrations of zinc on glutamateinduced calcium influx and neurotoxicity. A low Values are expressed as means (±S.D.). There were no significant differences among Before, Ischemia, and After, nor among the three drug groups.
concentration (under 100 µM) of zinc inhibited both glutamate-induced calcium influx and neuronal death ( Figs. 1 and 2 ). On the other hand, a higher concentration (over 150 µM) of zinc reduced neuronal viability. This neuronal death may due to the toxicity of the zinc itself, since glutamate-induced calcium influx was inhibited even at over 100 µM of zinc (Fig. 1) . These results indicate that a low concentration of zinc protects against glutamate-induced neuronal death by blocking calcium influx, whereas a high concentration exerts its own toxicity independent of calcium influx. Thus, zinc may exhibit biphasic effects depending on its concentration. Many groups have reported zinc toxicity (18 -21 translocates from the extracellular space into the living cells through ion channel site of NMDA receptors and the large amount of Ca 2+ moved into neurons was sequestered and accumulated in mitochondria (22, 23) , the 45 Ca 2+ in the dead cells would have been incorporated into these cells when they were alive. Thus, the data obtained in this study would indicate substantially the 45 Ca 2+ uptake occurred in the living cells, although further studies on the localization of 45 
Ca
2+ in the cells are required. The phenomenon that the 45 Ca 2+ uptake increased even at about 50% viability of the control (Figs. 1 and 3 ) could also support this argument.
Next, we examined the effect of chelation of endogenous zinc on ischemic neuronal injury in vitro and in vivo by using several chelating agents. TPEN and CaEDTA, which can bind zinc, enhanced glutamateinduced calcium influx and neurotoxicity in cultured hippocampal neurons. TPEN reduces intra-and extracellular zinc since it can permeate the neuronal cell membrane. In contrast, CaEDTA reduces only extracellular zinc that is released from synaptic vesicles by glutamate-induced stimulation since it can not permeate the neuronal cell membrane. Because the effect of CaEDTA was approximately the same as that of TPEN, the enhancement of calcium influx and neurotoxicity was due to a reduction in the amount of extra-cellular zinc released by the stimulation with glutamate. Furthermore, ZnEDTA had no effect on glutamate-induced calcium influx and neurotoxicity. Since EDTA has higher affinity for zinc than calcium, CaEDTA reduces zinc via a Ca
2+
-Zn 2+ exchange reaction, but ZnEDTA can not reduce zinc. Thus, the results for ZnEDTA also support that the effects of CaEDTA were due to reduction of extra-cellular zinc. Some groups have reported that zinc exerts an inhibitory effect against nerve excitation by blocking NMDA receptors (5 -7) . On the other hand, Bancila et al. (9) reports that chelation of endogenous zinc by CaEDTA during a brief anoxic-hypoglycemia reduced the inhibition of release of glutamate by zinc and aggravated cell damage in hippocampal slice cultures. Since high concentration of glutamate was added in our study, the blockage of calcium influx via NMDA receptor, rather than inhibition of endogenous glutamate release, may be the major mechanism of protection against the neurotoxicity of glutamate in our study.
In the MCAO study, the reduction in extra-cellular zinc on the i.c.v. injection of CaEDTA accelerated the early development of infarction (Fig. 5) . Because there were no significant differences in physiological parameters including rectal temperature throughout the ischemic period in the experiments, the results of CaEDTA could not be attributed to hypothermia or other alterations in physiological parameters (Table 1) . Regarding the distribution of CaEDTA in the extracellular space after i.c.v. injection, we examined it using Ca-[
14 C]EDTA (data not shown), and we confirmed that after the injection, Ca-[
14 C]EDTA diffused with time and reached maximum concentration in the lesioned area at 30 min. The concentration of Ca-[
14 C]EDTA in the lesioned area at 30 min after injection was about 230 nmol / g tissue, and it equals 230 µM if we assume that 1 g tissue is considered as 1 mL. Furthermore, since CaEDTA is only present in the extra-cellular space, the concentration of CaEDTA in the extracellular space is estimated to be 1.15 mM if we assume that the extracellular volume is about 20% of the total volume (24) . Probably, this concentration would satisfy the required concentration to reduce free zinc effectively. Furthermore, although the concentration of zinc released during ischemia has not been exactly determined, it is estimated to be in the low micromolar range (4, 25) or nanomolar range (26) . Thus, since a low concentration of zinc (under 100 µM) had a protective effect on the neurotoxicity of glutamate in a concentration-dependent manner in our in vitro study, the reduction of zinc caused by CaEDTA might reduce, at least in part, the protective effect of endogenous zinc and increase the infarction volume in the MCAO model. The results that the ZnEDTA-treated group exhibited no significant difference to the saline-treated group also supports this hypothesis. Furthermore, it has been reported that zinc transporter-3 (zincT-3)-null mice, which lack histochemically reactive zinc in synaptic vesicles, or zincdeficient mice are more sensitive to seizures induced with kainate (27, 28) . These reports also imply that vesicular zinc may exert an inhibitive effect on hyperexcitation.
On the other hand, at 24 h after ischemia, infarction volume in the saline-treated group was the same as that in the CaEDTA-treated group. The reason for this is not clear, but the type of cell death might differ between these groups. The type of cell death may vary depending on how much calcium is influxed into the cell, which in turn may depend on the amount of excitatory amino acids (29) , as low concentrations of excitatory amino acids induce an apoptosis-like cell death, whereas high concentrations induce necrotic cell death (30) . In our study, an excess influx of calcium due to a loss of endogenous zinc inhibition might have induced rapid necrotic cell death in the CaEDTA-treated group, and less calcium due to partial inhibition of endogenous zinc might induce an apoptosis-like cell death, which occurs more slowly than necrosis, in the saline-treated group.
Our results demonstrated that a low concentration of zinc exerts a protective effect against the neurotoxicity of glutamate and a high concentration of zinc exerts its own neurotoxicity. Furthermore, in the rat MCAO model, the reduction of released vesicular zinc caused by CaEDTA enhanced the early development of infarction after ischemia. Together with these results, it was suggested that vesicular zinc might exert a protective effect against ischemic neuronal injury. Although the detailed mechanism in vivo is not clear, at least in part, the inhibition of calcium influx might contribute to this issue.
